Kinase drug discovery remains an area of significant interest across academia
and in the pharmaceutical industry. There are now around 13 FDA approved small
molecule drugs which target kinases and many more compounds in various stages of
clinical development. Although there have been a number of reviews/publications
on kinase research, this book fills a gap in the literature by considering the
current and future opportunities and challenges in targeting this important
family of enzymes. The book is forward-looking and identifies a number of hot
topics and key areas for kinase drug discovery over the coming years. It
includes contributions from highly respected authors with a combined experience
in